Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema. Dermatol Reports [Internet]. 2022 Nov. 21 [cited 2025 Jun. 19];14(4). Available from: https://journals.pagepress.org/dr/article/view/9447